The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
dimethicone, octinoxate, octisalate, oxybenzone · Kit
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 20 mg/g; 75 mg/g; 30 mg/g; 30 mg/g · Ointment · #1 tube/blister pack / 2 g in 1 tube · 20 mg/g; 75 mg/g; 30 mg/g; 30 mg/g · Ointment · #2 tubes/blister pack / 2 g in 1 tube · 20 mg/g; 75 mg/g; 30 mg/g; 30 ug/g · Stick · #3 tubes/blister pack / 2 g in 1 tube
Common questions
- Is Dimethicone, octinoxate, octisalate, oxybenzone in shortage right now?
- No. FDA does not currently list Dimethicone, octinoxate, octisalate, oxybenzone in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Dimethicone, octinoxate, octisalate, oxybenzone?
- 1 company has marketed Dimethicone, octinoxate, octisalate, oxybenzone in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.